{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T22:15:58Z","timestamp":1794608158852,"version":"4.9.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T00:00:00Z","timestamp":1765324800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T00:00:00Z","timestamp":1768262400000},"content-version":"vor","delay-in-days":34,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","award":["NNF22OC0078062"],"award-info":[{"award-number":["NNF22OC0078062"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007596","name":"Sygeforsikringen \"danmark\"","doi-asserted-by":"publisher","award":["2022-0225"],"award-info":[{"award-number":["2022-0225"]}],"id":[{"id":"10.13039\/100007596","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005275","name":"Region Hovedstaden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005275","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001734","name":"Copenhagen University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001734","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"DOI":"10.1186\/s13063-025-09316-5","type":"journal-article","created":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T08:16:49Z","timestamp":1765354609000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Early shift to oral antibiotic treatment for pyogenic vertebral osteomyelitis (SAVE): study protocol for an open label, non-inferiority, nation-wide randomized controlled clinical trial"],"prefix":"10.1186","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-9217-3632","authenticated-orcid":false,"given":"Zahra Persson","family":"Theilgaard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Weis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pernille","family":"Ravn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter Haahr","family":"Bernhard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nis Pedersen","family":"J\u00f8rgensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesper Andreas","family":"Knudsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"\u00d6brink-Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iben","family":"\u00d8rsted","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristian","family":"Sch\u00f8nning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isik Somuncu","family":"Johansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Mette","family":"Lebech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,10]]},"reference":[{"key":"9316_CR1","doi-asserted-by":"crossref","unstructured":"Zimmerli W. Clinical practice. Vertebral osteomyelitis. N Engl J Med. 2010;362(11):1022\u20139.","DOI":"10.1056\/NEJMcp0910753"},{"key":"9316_CR2","doi-asserted-by":"crossref","unstructured":"Kehrer M, Pedersen C, Jensen TG, Lassen AT. Increasing incidence of pyogenic spondylodiscitis: a 14-year population-based study. J Infect. 2014;68:313\u201320.","DOI":"10.1016\/j.jinf.2013.11.011"},{"key":"9316_CR3","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1016\/j.spinee.2015.02.021","volume":"15","author":"M Kehrer","year":"2015","unstructured":"Kehrer M, Pedersen C, Gorm Jensen T, Hallas J, Lassen AT. Clinical study increased short-and long-term mortality among patients with infectious spondylodiscitis compared with a reference population. Spine J. 2015;15:1233\u201340.","journal-title":"Spine J"},{"key":"9316_CR4","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.ijid.2021.05.078","volume":"1;108","author":"C Geisler Crone","year":"2021","unstructured":"Geisler Crone C, Mose Tetens M, Bengaard Andersen A, Obel N, Lebech AM. Clinical characteristics of pyogenic vertebral osteomyelitis, and factors associated with inadequate treatment response. Int J Infect Dis. 2021;1;108:487\u201393.","journal-title":"Int J Infect Dis"},{"key":"9316_CR5","doi-asserted-by":"publisher","unstructured":"Dragsted C, Aagaard T, Ohrt-Nissen S, Gehrchen M, Dahl B. Mortality and health-related quality of life in patients surgically treated for spondylodiscitis. J Orthop Surg (Hong Kong). 2017;25(2):2309499017716068. https:\/\/doi.org\/10.1177\/2309499017716068. PMID: 28639530.","DOI":"10.1177\/2309499017716068"},{"key":"9316_CR6","doi-asserted-by":"crossref","unstructured":"Kinamon T, Dagher M, Park L, Ruffin F, Fowler VG, Maskarinec SA. Risk factors and outcomes of hematogenous vertebral osteomyelitis in patients with Staphylococcus aureus bacteremia. Clin Infect Dis. 2023;77(9):1226. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC10640688\/. Cited 2025 Jan 21.","DOI":"10.1093\/cid\/ciad377"},{"key":"9316_CR7","doi-asserted-by":"crossref","unstructured":"Aagaard T, Roed C, Dahl B, Obel N. Long-term prognosis and causes of death after spondylodiscitis: A Danish nationwide cohort study. 2015;48(3):201\u20138. http:\/\/dx.doi.org.ep.fjernadgang.kb.dk\/103109\/2374423520151103897.","DOI":"10.3109\/23744235.2015.1103897"},{"key":"9316_CR8","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1080\/23744235.2016.1217348","volume":"1;49(2)","author":"M Kehrer","year":"2017","unstructured":"Kehrer M, Hallas J, B\u00e6lum J, Jensen TG, Pedersen C, Lassen AT. Reduced ability to work both before and after infectious spondylodiscitis in working-age patients. Infect Dis. 2017;1;49(2):95\u2013103.","journal-title":"Infect Dis"},{"key":"9316_CR9","doi-asserted-by":"crossref","unstructured":"Berbari EF, Kanj SS, Kowalski TJ, Darouiche RO, Widmer AF, Schmitt SK, et al. 2015 Infectious Diseases Society of America (IDSA) clinical practice guidelines for the diagnosis and treatment of native vertebral osteomyelitis in adults. Clin Infect Dis. 2015;61(6):e26-46.","DOI":"10.1093\/cid\/civ482"},{"key":"9316_CR10","doi-asserted-by":"publisher","unstructured":"Bernard L, Dinh A, Ghout I, Simo D, Zeller V, Issartel B, et al. Antibiotic treatment for 6 weeks versus 12 weeks in patients with pyogenic vertebral osteomyelitis: an open-label, non-inferiority, randomised, controlled trial. Lancet. 2015;385(9971):875\u201382. https:\/\/doi.org\/10.1016\/S0140-6736(14)61233-2. Epub 2014 Nov 5. PMID: 25468170.","DOI":"10.1016\/S0140-6736(14)61233-2"},{"key":"9316_CR11","doi-asserted-by":"crossref","unstructured":"Park KH, Cho OH, Lee JH, Park JS, Ryu KN, Park SY, et al. Optimal duration of antibiotic therapy in patients with hematogenous vertebral osteomyelitis at low risk and high risk of recurrence. Clin Infect Dis. 2016;62(10):1262\u20139.","DOI":"10.1093\/cid\/ciw098"},{"key":"9316_CR12","unstructured":"Spondylodiscitis Diagnostik og behandling version 2, 2025. 2025. Available from: https:\/\/infmed.dk\/site\/tools\/download.php?UID=c9fbe386d5fd577eb77cf6f9085bfada8e6a3153. Cited 2025 Mar 21."},{"key":"9316_CR13","doi-asserted-by":"crossref","unstructured":"Miliani K, Taravella R, Thillard D, Chauvin V, Martin E, Phanie Edouard S, et al. Peripheral venous catheter-related adverse events: evaluation from a multicentre epidemiological study in France (the CATHEVAL Project). 2017.","DOI":"10.1371\/journal.pone.0168637"},{"issue":"3","key":"9316_CR14","doi-asserted-by":"publisher","first-page":"170","DOI":"10.4103\/2229-5151.164940","volume":"5","author":"C Kornbau","year":"2015","unstructured":"Kornbau C, Lee KC, Hughes GD, Firstenberg MS. Central line complications. Int J Crit Illn Inj Sci. 2015;5(3):170.","journal-title":"Int J Crit Illn Inj Sci"},{"key":"9316_CR15","doi-asserted-by":"crossref","unstructured":"Forrester JD, Maggio PM, Tennakoon L. Cost of health care-associated infections in the United States. J Patient Saf. 2022;18(2):E477\u20139.","DOI":"10.1097\/PTS.0000000000000845"},{"key":"9316_CR16","unstructured":"Nosocomial infections in medical intensive care units in the United States. Available from: https:\/\/oce-ovid-com.ep.fjernadgang.kb.dk\/article\/00003246-199905000-00020\/HTML. Cited 2023 Feb 27."},{"key":"9316_CR17","doi-asserted-by":"crossref","unstructured":"Walker IV FB, Novack DH, Kaiser DL, Knight A, Oblinger P. Anxiety and depression among medical and surgical patients nearing hospital discharge. J Gen Intern Med. 1987;2(2):99\u2013101.","DOI":"10.1007\/BF02596305"},{"key":"9316_CR18","doi-asserted-by":"crossref","unstructured":"Chen Y, Almirall-S\u00e1nchez A, Mockler D, Adrion E, Dom\u00ednguez-Vivero C, Romero-Ortu\u00f1o R. Hospital\u2010associated deconditioning: not only physical, but also cognitive. Int J Geriatr Psychiatry. 2022;37(3):1\u201313.","DOI":"10.1002\/gps.5687"},{"key":"9316_CR19","doi-asserted-by":"publisher","unstructured":"Spellberg B, Lipsky BA. Systemic antibiotic therapy for chronic osteomyelitis in adults. Clin Infect Dis. 2012;54(3):393\u2013407. https:\/\/doi.org\/10.1093\/cid\/cir842. Epub 2011 Dec 12. PMID: 22157324; PMCID: PMC3491855.","DOI":"10.1093\/cid\/cir842"},{"key":"9316_CR20","doi-asserted-by":"crossref","unstructured":"Iversen K, Ihlemann N, Gill SU, Madsen T, Elming H, Jensen KT, et al. Partial oral versus intravenous antibiotic treatment of endocarditis. New England J Med. 2019;380(5):415\u201324.","DOI":"10.1056\/NEJMoa1808312"},{"key":"9316_CR21","doi-asserted-by":"crossref","unstructured":"Pries-Heje MM, Wiingaard C, Ihlemann N, Gill SU, Bruun NE, Elming H, et al. Five-year outcomes of the partial oral treatment of endocarditis (POET) Trial. New England J Med. 2022;386(6):601\u20132.","DOI":"10.1056\/NEJMc2114046"},{"key":"9316_CR22","doi-asserted-by":"crossref","unstructured":"Li HK, Rombach I, Zambellas R, Walker AS, McNally MA, Atkins BL, et al. Oral versus intravenous antibiotics for bone and joint infection. New England J Med. 2019;380(5):425\u201336.","DOI":"10.1056\/NEJMoa1710926"},{"key":"9316_CR23","doi-asserted-by":"crossref","unstructured":"Eichenberger EM, De Vries CR, Ruffin F, Sharma-Kuinkel B, Park L, Hong D, et al. Microbial cell-free DNA identifies etiology of bloodstream infections, persists longer than conventional blood cultures, and its duration of detection is associated with metastatic infection in patients with Staphylococcus aureus and gram-negative bacteremia. Clin Infect Dis. 2022;74(11):2020.","DOI":"10.1093\/cid\/ciab742"},{"key":"9316_CR24","doi-asserted-by":"crossref","unstructured":"Goggin KP, Gonzalez-Pena V, Inaba Y, Allison KJ, Hong DK, Ahmed AA, et al. Evaluation of plasma microbial cell-free DNA sequencing to predict bloodstream infection in pediatric patients with relapsed or refractory cancer. JAMA Oncol. 2020;6(4):552.","DOI":"10.1001\/jamaoncol.2019.4120"},{"key":"9316_CR25","doi-asserted-by":"publisher","unstructured":"Howard P, Covino M, Daly AK. Relevance of pharmacogenomics to the safe use of antimicrobials. Antibiotics (Basel). 2023;12(3):425. https:\/\/doi.org\/10.3390\/antibiotics12030425. PMID: 36978292; PMCID: PMC10044203.","DOI":"10.3390\/antibiotics12030425"},{"key":"9316_CR26","doi-asserted-by":"publisher","unstructured":"Wang CW, Arni I, Preclaro C, Lin WH, Chung WH. An updated review of genetic associations with severe adverse drug reactions: translation and implementation of pharmacogenomic testing in clinical practice. Front Pharmacol. 2022;13:886377. https:\/\/doi.org\/10.3389\/fphar.2022.886377. PMID: 35548363; PMCID: PMC9081981.","DOI":"10.3389\/fphar.2022.886377"},{"key":"9316_CR27","doi-asserted-by":"crossref","unstructured":"Stocco G, Lucaf\u00f2 M, Decorti G. Pharmacogenomics of antibiotics. Int J Mol Sci. 2020;21(17):1\u201320.","DOI":"10.3390\/ijms21175975"},{"key":"9316_CR28","doi-asserted-by":"crossref","unstructured":"Haugaard AK, Marquart H V., Kolte L, Ryder LP, Kehrer M, Krogstrup M, et al. Quantitative B-lymphocyte deficiency and increased TCR\u03b3\u03b4 T-lymphocytes in acute infectious spondylodiscitis. Sci Rep. 2018;8(1):15174.","DOI":"10.1038\/s41598-018-33318-w"},{"key":"9316_CR29","doi-asserted-by":"crossref","unstructured":"Tangye SG, Al-Herz W, Bousfiha A, Cunningham-Rundles C, Franco JL, Holland SM, et al. Human inborn errors of immunity: 2022 update on the classification from the International Union of Immunological Societies Expert Committee. J Clin Immunol. 2022;42(7):1473.","DOI":"10.1007\/s10875-022-01289-3"},{"key":"9316_CR30","doi-asserted-by":"crossref","unstructured":"Oton-Gonzalez L, Mazziotta C, Iaquinta MR, Mazzoni E, Nocini R, Trevisiol L, et al. Genetics and epigenetics of bone remodeling and metabolic bone diseases. Int J Mol Sci. 2022;23(3):1500.","DOI":"10.3390\/ijms23031500"},{"key":"9316_CR31","doi-asserted-by":"crossref","unstructured":"Treibich C, Ventelou B. Validation of a short-form questionnaire to check patients\u2019 adherence to antibiotic treatments in an outpatient setting. Eur J Public Health. 2017;27(6):978\u201380.","DOI":"10.1093\/eurpub\/ckx146"},{"key":"9316_CR32","doi-asserted-by":"crossref","unstructured":"Feng YS, Kohlmann T, Janssen MF, Buchholz I. Psychometric properties of the EQ-5D-5L: a systematic review of the literature. Qual Life Res. 2021;30(3):647\u201373.","DOI":"10.1007\/s11136-020-02688-y"},{"key":"9316_CR33","doi-asserted-by":"crossref","unstructured":"Bernard L, Dinh A, Ghout I, Simo D, Zeller V, Issartel B, et al. Antibiotic treatment for 6 weeks versus 12 weeks in patients with pyogenic vertebral osteomyelitis: an open-label, non-inferiority, randomised, controlled trial. Lancet. 2015;385(9971):875\u201382.","DOI":"10.1016\/S0140-6736(14)61233-2"},{"key":"9316_CR34","unstructured":"L\u00e6gemiddelstyrelsen (The Danish Medicines Agency). L\u00e6gemiddelstyrelsens vejledning om risikotilpasset bivirkningsregistrering og rapportering i kliniske fors\u00f8g med l\u00e6gemidler under forordning (EU) nr. 536\/2014. Version 1.0. 2023;1\u201316. Available from: https:\/\/laegemiddelstyrelsen.dk\/da\/nyheder\/2023\/risikotilpasset-bivirkningsregistrering-og-rapportering-i-kliniske-forsoeg-med-laegemidler-er-nu-muligt\/~\/media\/8E1AFBB2C13C47E19D088765F917116C.ashx.\u00a0Accessed Sept 2024."},{"key":"9316_CR35","doi-asserted-by":"crossref","unstructured":"Schulz KF, Grimes DA. Multiplicity in randomised trials II: subgroup and interim analyses. Lancet. 2005;365(9471):1657\u201361.","DOI":"10.1016\/S0140-6736(05)66516-6"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-025-09316-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-025-09316-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-025-09316-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T15:51:43Z","timestamp":1768319503000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13063-025-09316-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,10]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9316"],"URL":"https:\/\/doi.org\/10.1186\/s13063-025-09316-5","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,10]]},"assertion":[{"value":"10 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study has received approval from the Danish Medical Research Ethics Committees and the Danish Medicines Agency. Date of approval 27-11-2023, reference number EU CT Nr 2023\u2013507617-96-01. Written, informed consent to participate will be obtained from all study participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"36"}}